By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101



Company News
BioLineRx Ltd. Presents Multi-Year Clinical Development Plan For Its BL-8040 Hematological Cancer Therapeutic Platform 12/12/2014 9:04:04 AM
BioLineRx Ltd. Reports Positive Data from Ongoing Phase 2a Study for AML Treatment at American Society of Hematology Conference 12/8/2014 10:52:11 AM
BioLineRx Ltd. Reports Third Quarter 2014 Financial Results 11/10/2014 10:12:57 AM
BioLineRx Ltd. Announces Successful Final Results Of Phase 1/2 Study For Novel Celiac Treatment 11/5/2014 9:35:52 AM
BioLineRx Ltd. Files Protocol Amendment To Phase 2 Study For AML Treatment Based On Encouraging Efficacy And Strong Safety Profile 11/3/2014 10:54:36 AM
BioLineRx Ltd. To Report Third Quarter 2014 Results On November 10, 2014 11/3/2014 10:04:30 AM
BioLineRx Ltd. Reports Publication In Peer Review Journal Of Results From Previous Phase 1/2 Trial For BCM (BL-1040), A Novel Medical Device For Prevention Of Cardiac Remodeling Following Acute Myocardial Infarction 10/31/2014 9:15:26 AM
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014 9:36:05 AM
BioLineRx Ltd. Doses First Patient For BL-8040’s Second Indication As Novel Stem Cell Mobilization Treatment 9/3/2014 10:50:33 AM
BioLineRx Ltd. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York 9/2/2014 11:06:14 AM